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ABSTRACT  When monolayer cultures of Chinese hamster lung fibroblasts are briefly incubated 
at 2°C with the fluorescent  sphingolipid analogue, C6-NBD-ceramide  (N-[7-(4-nitrobenzo-2- 
oxa-l,3-diazole)] aminocaproyl sphingosine), fluorescent  labeling of the mitochondria, endo- 
plasmic reticulum, and nuclear envelope occur.  During further incubation at 37°C, the Golgi 
apparatus, and later the plasma membrane,  become intensely fluorescent.  Within this period, 
the  C6-NBD-ceramide  is  converted  to  equal  amounts  of  fluorescent  sphingomyelin  and 
glucocerebroside  (Lipsky, N. G., and R. E. Pagano, 1983, Proc. Natl. Acad. Sci. USA., 80:2608- 
2612).  In  the  present  study,  the  intracellular  translocation  of these  metabolites  and  their 
subsequent appearance at the plasma membrane  were investigated by fluorescence  micros- 
copy, the addition  of the  ionophore  monensin,  and the technique  of "back  exchange,"  in 
which the amounts  and types of fluorescent  lipids  present at the cell surface are identified 
after their transfer from the cell surface into recipient vesicles. In control cells, the amount of 
fluorescent  glucocerebroside  and sphingomyelin  that could be removed from the cell surface 
by  back  exchange  increased  during  incubation  at  37°C,  correlating  with  the  increased 
fluorescence  of the plasma membrane  observed  by microscopy.  In the presence of 10 #M 
monensin, visible labeling of the plasma membrane was greatly diminished,  whereas the Golgi 
apparatus became highly fluorescent  and distended. The ability to remove fluorescent  metab- 
olites  from  the cell  surface by back exchange  was significantly  but reversibly  inhibited  by 
monensin.  Monensin also increased the total  amount of fluorescent  sphingomyelin,  but not 
the glucocerebroside  found in cells. 
Subcellular  fractions were assayed for their ability to convert  radiolabeled  and fluorescent 
ceramides  to  the  corresponding  sphingomyelins  and  glucocerebrosides.  The  activities  of 
parallel fractions  coincided,  suggesting that  the presence of the NBD moiety did not affect 
the cellular  metabolism  of ceramide.  Furthermore,  the  major  peak of sphingomyelin-  and 
glucocerebroside-synthesizing  activity appeared to coincide with an enriched  Golgi fraction. 
These results strongly  suggest that  fluorescent  sphingomyelin  was  not synthesized  at the 
plasma membrane  as has recently been  suggested for endogenous  sphingomyelin.  Rather, 
both the sphingomyelin and glucocerebroside  analogues were synthesized intracellularly  from 
C6-NBD-ceramide  and translocated through the Golgi apparatus to the cell surface. 
The sites of lipid biosynthesis in animal cells and the mecha- 
nism(s)  by  which  newly  synthesized  molecules are  subse- 
quently translocated to various intracellular membranes pose 
many  fundamental  but,  as  yet,  unresolved  questions  for 
biochemists and cell biologists.  Sphingomyelin, the predomi- 
nant sphingolipid in many cell types, illustrates this point (1). 
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proposed. The long-standing evidence that the donor of the 
phosphorylcholine moiety of this molecule is CDP-choline 
(2-4) has recently been challenged in favor of phosphatidyl- 
choline as the more likely donor (5-10). The site of sphingo- 
myelin biosynthesis is also in dispute. The earliest studies (3) 
indicating that synthesis occurred in a  microsomal fraction 
were  based  on  the  use  of the  nonnatural  threo-ceramide 
isomer, and employed CDP-choline as the phosphorylcholine 
donor. In a more recent study that used the naturally occur- 
ring D-erythroceramide and phosphatidylcholine precursors, 
Ullman and Radin (5) found activity in a crude liver micro- 
somal fraction, and later Bernert and Ullman (6) established 
this for other tissues as well. Unfortunately, this crude micro- 
somal fraction may have contained endoplasmic reticulum, 
Golgi apparatus, and plasma membrane. Marggraf et al. (8) 
found  significant  activity  in  a  very light  sucrose  fraction, 
which they identified as plasma membrane. However, their 
later study (11) revealed the activity to actually be present in 
a Golgi fraction, a Golgi apparatus-plasma membrane frac- 
tion,  and  a  plasma membrane fraction.  They note  in  this 
report  that  5'-nucleotidase,  considered  a  marker  for  the 
plasma membrane, was found to an equal degree in the Golgi 
fraction  (this  has  also  been  shown  cytochemically  [12]). 
Voelker and Kennedy (7), in an elegant study that established 
phosphatidylcholine as the appropriate precursor for sphin- 
gomyelin biosynthesis, went on to find significant synthetic 
activities in a plama membrane fraction. However, this frac- 
tion was characterized on the basis of 5'-nucleotidase activity 
and was not assayed for the presence of Golgi membranes. 
Sphingomyelin synthetic activity has also been  reported in 
mitochondria ( 13,  14). 
In the present study, we address the issues of the site(s) of 
synthesis  and  route(s)  of translocation  of sphingolipids  in 
cultured fibroblasts, by using a  fluorescent analogue of cer- 
amide. This approach has the advantage that the fluorescent 
ceramide and its metabolites may be visualized in living cells 
by fluorescence microscopy (15), and thus information on the 
intracellular distribution of these molecules may be obtained 
without fixation or cell disruption.  These data can then be 
correlated with standard lipid biochemical analyses. 
MATERIALS AND  METHODS 
Materials 
Chemicals were  purchased from the indicated  sources:  Eagle's minimal 
essential medium (Gibco  Laboratories,  Grand  Island,  NY);  lectins (Vector 
Laboratories, Inc., Burlingame, CA); ovalbumin grade V, UDP-glueose, UDP- 
galactose,  sphingosine, and  sphingosine-l-phosphocholine (Sigma Chemical 
Co,  St.  Louis,  MO);  dioleoyl  phosphatidyl choline (DOPC) 1 and N-[7-(4- 
nitrobenzo-2-oxa-  1,3-diazole)] aminocaproic acid (C~-NBD-aminocaproic  acid: 
(Avanti Biochemicals Birmingham, AL); Aquasol, [9,10-~H(N)]  palmitic acid 
(23.5  Ci/mmol), and  [galactose-4,53H(N)]  UDP-galactose (48.5  Ci/mmol) 
~  Abbreviations  used in this paper: DOPC, dioleoyl phosphatidylcho- 
line;  HMEM,  HEPES-buffered  Eagle's minimal essential medium, 
pH 7.4, without indicator, plus 0.62 mM PO4; C6-NBD-aminocaproic 
acid,  N-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]  aminocaproic  acid;  C6- 
NBD-ceramide,  N-[ 7-(4-nitrobenzo-2-oxa- 1,3-diazole)]-6-aminoca- 
proyl  sphingosine; C6-NBD-glucocerebroside,  N-[7-(4-nitrobenzo-2- 
oxa-l,3-diazole)]-6-minocaproyl  sphingosine  glucoside;  C6-NBD- 
sphingomyelin,  N-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]-6-aminoca- 
proyl  sphingosine-l-phosphocholine;  NBD-glucocerebroside,  N-[7- 
(4-nitrobenzo-2-oxa-l,3-diazole)]  aminoacyl  sphingosine  glucoside; 
NBD-sphingomyelin, N-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]  amino- 
acyl sphingosine-  1  -phosphocholine. 
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(New  England Nuclear,  Boston,  MA);  and  monensin (Calbiochem-Behring 
Corp., San Diego, CA). ~251-wheat  germ agglutinin was the generous gift of Ms. 
J. Lippincott-Schwartz,  Carnegie Institution of Washington, and glucosylsphin- 
gosine was obtained from Dr. Shimon Gatt (Hebrew  University). 
Preparation of Lipids 
N-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]-6-aminocaproyl  sphingosine  (C6- 
NBD-ceramide); N-[7-(4-nitrobenzo-2-oxa-  1,3-diazole)]-6-aminocaproyl  sphin- 
gosine glucoside  (C6-NBD-glucocerebroside);  and  N-[7-(4-nitrobenzo-2-oxa- 
1,3-diazole)]-6-aminocaproyl  sphingosine-l-phosphocholine (C6-NBD-sphin- 
gomyelin) were synthesized from C6-NBD-aminocaproic acid and sphingosine, 
glucosylsphingosine,  and sphingosine-l-phosphocholine,  respectively (16). The 
concentrations of NBD-labeled  lipids were determined fluorometrically (exci- 
tation 470 nm; emission 530 nm), and for C6-NBD-sphingomyelin, by phos- 
phate analysis (17) as well. Palmitoyl sphingosine and [9,103H(N)] palmitoyl 
sphingosine were synthesized (16) and were entirely in the o-erythro form as 
judged by  high-pressure liquid  chromatography (studies performed by  Dr. 
Yasuo Kishimoto, Johns Hopkins School of Medicine).  [9,10-3H(N)] palmitoyl 
sphingosine was radiographically  pure by thin-layer chromatography. 
Vesicle Preparation 
Small unilamellar fluorescent vesicles were formed by ethanol injection ( 18): 
23 mol% C6-NBD-ceramide-77% DOPC or  14 tool%  C6-NBD-glucocerebro- 
side or C6-NBD-sphingomyelin-86% DOPC were mixed, dried under nitrogen 
and then under reduced pressure, and made to 2.8 mM total lipids in ethanol. 
This mixture was injected  into 13 vol of 10 mM HEPES-buffered  calcium- and 
magnesium-free Puck's saline,  dialyzed at 2"C overnight against this buffer, 
then diluted with HEPES-buffered  Eagle's minimal essential medium (HMEM) 
to a  final concentration of 5-10  nmol NBD lipid/ml.  DOPC  vesicles were 
prepared  in  the same manner, except the DOPC  was made to  28  mM in 
ethanol, and the vesicles were dialyzed  against HMEM and brought to a final 
concentration of 1.1 mM in HMEM. 
Cell Culture and Incubations with Vesicles 
Monolayer cultures of Chinese hamster V79  fibroblasts  were  grown  to 
confiuency in Eagle's minimal essential medium supplemented with glutamine, 
gentamicin, fungizone, streptomycin sulfate, penicillin G, and 12% horse serum 
in a water-saturated atmosphere of 5% CO2 in air.  For fluorescent labeling, 
cultures were washed twice and incubated for 0.5  h in HMEM at 37"C, and 
then incubated with fluorescent vesicles in HMEM for 0.5 h at 2°C. Cultures 
were washed three times with HMEM, and then further incubated in HMEM 
at 37"C for the indicated times. For back-exchange studies, cultures were next 
incubated with DOPC vesicles for  15 rain at 2"C, the medium was removed, 
and the incubation was repeated with additional DOPC vesicles. A parallel set 
of monolayer cultures was incubated with two changes of  HMEM only. Cultures 
were washed three times with HMEM, scraped offthe dish, and cellular lipids 
were extracted and analyzed (19). Where indicated, all of the above solutions 
contained 10 uM monensin. A 40 mM solution of monensin in ethanol was 
made fresh before use, diluted to 100 t~m with HMEM, and then further diluted 
to a  final  concentration of 10 uM with the indicated incubation media. An 
equivalent amount of ethanol was present in all control solutions. 
Microscopy 
Fibroblasts were  grown  on  rat  tail  collagen-coated  glass coverslips,  and 
incubated as described above. For Golgi apparatus co-localization  studies, C6- 
NBD-ceramide-treated cells were first photographed for NBD fluorescence and 
then a Golgi apparatus-staining  procedure (20) was followed with modifications 
(15). A Zeiss universal microscope (Carl Zeiss, Inc. New York) equipped with 
epi-illumination for fluorescence was used. 
Thin-layer Chromatography 
Cellular lipid extracts were applied to silica gel 60 thin-layer plates (Merck 
& Co., Rahway, N J) and developed in CHCI~/CH3OH/H20 (65:25:4). Fluores- 
cent lipids were detected by ultraviolet illumination, and quantified by reference 
to  synthetic standards with a  Coming 750  scanning densitometer (Corning 
Medical and Scientific, Corning Glass Works, Medfield,  MA). 
Protein 
Protein was estimated by absorbance at 280 nm and/or the Lowry procedure 
(21), There was good agreement between the two methods. DNA Measurement 
Aliquots of cell suspensions were precipitated in 0.2 N-perchloric acid and 
hydrolyzed, and DNA was estimated spectrophotometrically (22). 
Subcellular  Fractionation 
Subcellular fractions were prepared by a  modification of the procedure of 
Snider and Robbins (23).  Cells were washed and scraped offthe dish with PBS, 
centrifuged, and then resuspended in 10 mM Tris HCI, pH 7.4,  I mM MgCI2 
at ~ I x  107 cells/ml for 20 rain at 2"C. The suspension was homogenized with 
25 strokes in a loose-fitting Dounce homogenizer, 0.5 vol of 0.75 M  sucrose- 
I0 mM Tris HCI, pH 7.4,  I mM MgCI2, was added, and this was centrifuged 
at 600 g to sediment nuclei. The supernatant was centrifuged at I00,000 g for 
45 rain in an SW41 rotor (Beckman Instruments, Inc., Fullerton, CA), and the 
pellet was resuspended in 0.25  M  sucrose-10 mM Tris HC1,  pH  7.4,  1 mM 
EDTA.  This "membrane pellet" (0.8-1.2  mg of protein) was layered over a 
gradient containing t.7 ml each of 50, 40, 35, 30, 25, and  15% sucrose in i0 
mM Tris HCI, pH 7.4,  1 mM EDTA. Gradients were centrifuged at 100,000 g 
for 16 h in an SW41 rotor, and 0.5-ml fractions were collected and the percent 
sucrose  was  estimated  with  a  refractometer.  Fractions  were  centrifuged  at 
100,000 g  for 45  rain in a  50.2  Ti rotor (Beckman  Instruments, Inc.), and 
pellets were resuspended in 10 mM Tris HC1, pH 7.4. Aliquots of each fraction 
were frozen and enzymatic activity was assayed within 24 h. 
RESULTS 
Monensin Affects lntracellular Distribution 
of Fluorescence 
When  flbroblast monolayers were incubated briefly with 
C6-NBD-ceramide-containing vesicles at  2"C,  washed,  and 
warmed 30 min at 37"C in HMEM, intense labeling was seen 
in a perinuclear region and to a lesser degree in mitochondria 
and endoplasmic reticulum (Fig.  1A). Within 2 h, the plasma 
membrane became visibly labeled (Fig.  1 C). In the presence 
of 10 uM monensin, two major differences were noted. First, 
the bright, perinuclear fluorescence seen after 30 min became 
even more intense, and appeared to occupy a  larger, more 
diffuse area (Fig.  1B).  In addition, mitochondria assumed a 
spherical  shape,  rather  than  their  more  typical  elongated 
"threadlike" form. The second major difference was the sig- 
nificant reduction in plasma membrane labeling seen after 2 
h at 37°C (Fig.  1 D). Cell viability, as assessed by trypan blue 
exclusion, was unaffected by Cr-NBD-ceramide or monensin 
treatments. 
Enzyme and Marker Assays 
PLASMA  MEMBRANE:  Monolayer cultures were incubated for 30 min at 
2"C with t2~I-wheat germ agglutinin (9.2 x  108 cpm/mg) (24), washed, and then 
subjected to subcellular  fractionation. The specific radioactivity  in each fraction 
was measured before and after protein precipitation. No difference was found 
in the activity profile except in the very-low-density region, indicating that all 
significant peaks represented protein-bound t25I. 
GOLGI  APPARATUS:  Galactosyltransferase was measured by a  modifi- 
cation of the procedure of Bretz el al. (25). The reaction mixture contained 40 
mM sodium cacodylate, pH 7.0, 40 mM MnCI2, 40 mM 2-mercaptoethanol, 
17.5 mg/ml ovalbumin, 2 mM ATP, 0.4% Triton X-100,  1/~Ci [galactose-4,5- 
3H(N)] UDP-galactose, 0.5 mM UDP-galactose, and 5-10 #g of protein sample, 
in a fluid volume of 0.1  ml. After incubation at 37"C for 30 min, an additional 
50 nmol UDP-galactose was added. Proteins were precipitated and washed with 
trichloroacetie acid at 2"C, digested with  100 h  1 N  NaOH,  and neutralized 
with 20 ~, 6  N  HCI. Then 5  ml of Aquasol was added, and radioactivity was 
measured.  The  lysosomal enzyme marker ~-hexosaminidase was assayed as 
described (24). 
SPHINGOMYELIN  AND  GLUCOCEREBROSIDE  SYNTHESIS  ASSAYS: 
Sphingomyelin synthesis from Cr-NBD-ceramide was initially assayed by the 
method of Voelker and Kennedy (7). However, to avoid the use of detergents, 
an alternative assay system was used that gave identical results. This procedure 
is a  modification of that of Costantino-Ceccarini and Cestelli (26): Cr-NBD- 
ceramide or [9,10-3H(N)]  palmitoyl sphingosine was mixed with DOPC, and 
the lipids were desiccated. To this was added a solution of 130 mM KCI,  10 
mM Tris HCI, pH 7.4, for final lipid concentrations of 670/~M ceramide and 
1.3 mM DOPC. After 30 rain at 25"C, the mixture was sonicated in a Bransonic 
12  water  bath  sonicator  (Branson  Sonic  Power  Co.,  Danbury,  CT)  until 
completely resuspended (5-10 s). Assay reagents were added to the sample (5- 
10 ~g of protein), then the reaction was started with the addition of liposomes. 
20 nmol of Cr-NBD-ceramide or [9,10-3H(N)] palmitoyl sphingosine (2 x  106 
cpm) and 40 nmol of DOPC were present in each assay. After incubation of 
the reaction mixture at 37"C for  15 rain, lipids were extracted and applied to 
silica gel 60 plates. NBD lipids were separated in CHCI3/CH3OH/H20/NH4OH 
72:48:9:2 (6).  Fluorescent spots were quantified by scanning densitometry. 3H- 
lipids  were  separated  first  in  CHCI3/CH3OH/H20  65:25:4,  then  CHCI~/ 
CHaOH/2 N NH4OH 40:10:1 in the same dimension. Radioactive plates were 
sprayed with 7%  2,5-diphenyloxazole in acetone,  and  autoradiograms were 
prepared. Radioactive spots were then scraped and counted. This assay results 
in  the  production  of both  sphingomyelin and glucocerebroside. These were 
identified by their behavior on silica gel plates in several solvent systems (and 
on  borate-treated plates for the glueocerebroside) and  by resistance to  mild 
alkaline hydrolysis. 
Calculation of results 
The percent of NBD lipids removed by back exchange was calculated as 100 
x  (I-amount present with back exchange/amount present without back ex- 
change).  All  values were  on  a  per  DNA  basis.  Statistical significance was 
evaluated with a Student's t test. 
The Intensely Labeled Region Is the 
Golgi Apparatus 
We have previously demonstrated that the perinuclear re- 
gion described in Fig.  1  A corresponds to the Golgi apparatus 
(15). To determine the identity of the highly labeled area seen 
in the presence of monensin (Fig.  I,B and D), we carded out 
co-localization studies with  rhodamine-labeled wheat germ 
agglutinin, a lectin that preferentially labels the Golgi appa- 
ratus (20).  Fig.  2  demonstrates the co-localization of NBD 
fluorescence with the lectin.  It was apparent that the NBD- 
labeled  structure  corresponded  to  the  Golgi  apparatus  in 
monensin-treated cells. 
Arrival of NBD Lipids at the Plasma Membrane 
The identity of the compounds present at the plasma mem- 
brane of fluorescently labeled  monolayers was investigated 
using "back exchange." In this procedure Cr-NBD-lipids pres- 
ent in the plasma membrane of labeled cells are transferred 
into nonfluorescent recipient DOPC vesicles (27). The vesicles 
and cells can be separated, and the fluorescent lipids present 
in each can be extracted and quantified. This technique was 
applied in  the  present study in  an attempt to remove and 
analyze those NBD lipids present in the plasma membranes 
of NBD-ceramide-labeled cells. 
Several features of back exchange were investigated before 
the technique was applied to Cr-NBD-ceramide-treated cells 
(Table I).  This data was obtained from cells  that had been 
labeled with exogenously supplied Cr-NBD-sphingomyelin or 
C6-NBD-glucocerebroside rather than by allowing these lipids 
to be synthesized endogenously by metabolism of Cr-NBD- 
ceramide. At 2"C, these compounds reside exclusively in the 
plasma membrane as determined by fluorescence microscopy 
(reference 28 and data not shown) and thus provide a model 
system for testing back exchange efficiency. The maximum 
amount of each compound which could be removed from the 
plasma membrane by this method was 88% for the Cr-NBD- 
sphingomyelin and  85%  for Cr-NBD-glucocerebroside. The 
presence of monensin  in  the  incubation  medium  did  not 
affect the efficiency of back exchange. These results indicated 
that back exchange should efficiently remove almost all of 
the  NBD-sphingomyelin  and  NBD-glucocerebroside  that 
LtPslgY AND  PAGANO  lntraceffular  Transfocation o[ Sphingolipids  29 FIGURE  1  Intracellular fluorescence in the presence and absence of monensin: cells were incubated with  C6-NBD-ceramide 
containing vesicles at 2°C, washed, and incubated at 37°C in HMEM for 30 min (A and B) or 2 h (C and D). For B and D, all steps 
were in the presence of 10 ~M monensin. Bar, 10/~m. 
might appear at the plasma membrane following the metab- 
olism of C6-NBD-ceramide. When cultures labeled for 60 min 
at 2°C with C6-NBD-sphingomyelin or C6-NBD-glucocerebro- 
side were washed and incubated for 30 min at 37"C, plasma 
membrane labeling decreased, while internal or cytoplasmic 
fluorescence  became  visible  (reference  28  and  data  not 
shown). Following this incubation, the amount of fluorescent 
lipid which could be removed by back exchange decreased 
from  -90%  to  ~70%  for  NBD-sphingomyelin  and  from 
-90% to ~60% for NBD-glucocerebroside (data not shown). 
Fluorescence  microscopy of these  ceils indicated  that  after 
back exchange, no plasma membrane fluorescence remained, 
while strong cytoplasmic fluorescence was still visible.  These 
results suggest that NBD-lipids inside the cell are much less 
accessible to back exchange. Similar findings have previously 
been reported using a  fluorescent analogue of phosphatidyl- 
choline (27). 
Fig.  3  shows the  results  of a  back exchange  experiment 
using cells that were first incubated with vesicles containing 
C6-NBD-ceramide for 60 min at 2"C,  washed, and then in- 
cubated at 37"C.  At various intervals they were either sub- 
jected  to  back  exchange,  or,  for  controls,  incubated  in 
HMEM.  Cell  lipids were extracted  and  separated  by thin- 
layer chromatography. The amount of each fluorescent lipid 
present in  the control  and back exchanged cells was deter- 
mined and normalized to cell DNA, and the percent removed 
30  THE JOURNAL OF  CELL BIOLOGY • VOLUME  100,  1985 FIGURE 2  Co-localization of fluorescence in the presence of monensin to the Golgi apparatus: cells were incubated with Cr- 
NBD-ceramide-containing  vesicles at 20C, washed, and incubated in HMEM at 37"C fora half hour. They  were then photographed 
for NBD fluorescence (A). Monolayers were then treated as described  in Materials and Methods with Golgi apparatus staining 
rhodamine-labeled  wheat germ agglutinin, and the same field was rephotographed  for rhodamine  fluorescence (B). All prefixation 
steps were in the presence of 10/~M monensin. Bar, 10/sm. 
TABLE  I 
Efficiency of Back Exchange with Exogenously Supplied NBD Lipids in the Presence and Absence of Monensin 
-DOPC Vesicles 
pmol 
+DOPC Vesicles 
% Removed by 
back exchange 
A.  Cr-NBD-sphingomyelin  Control  2,828 ___ 171  349 __+ 31  88 
10/~M  monensin  3,039 +  152  238 _  14  92 
B.  Cr-NBD-glucocerebroside  Control  2,823 +  16  428 +  10  85 
10 #M monensin  2,958 +  84  530 ___ 23  82 
Cells  were incubated tor 0.5 h at 2"C  with vesicles  containing either (A) Cr-NBD-sphingomyelin  or (/3) Cr-NBD-glucocerebroside. They were washed and 
incubated at 2"C with HMEM (-DOPC vesicles), or subjected to back exchange  (+DOPC vesicles), as described  in Materials  and Methods. Where indicated, 
all steps were in the presence  of 10 .aM monensin_ Values are pmol NBD lipid/mg cell  DNA, and represent  mean +  SD of three independent experiments. 
by back exchange was calculated.  Fig.  3  demonstrates that 
between 5 and 15 min at 37"C, 30% of the total cellular NBD- 
sphingomyelin and NBD-glucocerebroside were removed by 
this procedure. After 45  rain, almost 60% was removed. In 
contrast,  only ~ 15%  of the Cr-NBD-ceramide could be re- 
moved  at  any  time.  These  results  suggest  that  increasing 
fractions of each fluorescent metabolite became localized to 
the  plasma  membrane  over time,  in  agreement  with  the 
increasing fluorescence observed at the plasma membrane by 
microscopy (Fig.  I,A and C). 
It is difficult to establish whether back exchange overesti- 
mates the amount of NBD-lipid present at the plasma mem- 
brane by removing some fluorescent lipid from the cell inte- 
rior.  This may be the case since at early stages of the  37°C 
incubation (e.g.,  5 min),  15-20% of the NBD-ceramide, and 
25-30%  each of NBD-sphingomyelin and -glucocerebroside 
could be removed by back exchange (Fig. 3), even though no 
plasma  membrane  labeling  could  be  seen  by  fluorescence 
microscopy. This absence of plasma membrane labeling was 
not because the levels of NBD-metabolites were too low to 
be seen since exogenously supplied C6-NBD-cerebroside or 
-sphingomyelin  present  in  the  plasma  membrane  at  these 
concentrations was readily observed. While some removal of 
NBD-lipids from the cell interior may have occurred during 
back exchange, this  can  only cause an  overestimate of the 
amounts  of NBD-lipids  present  at  the  plasma membrane. 
Such an overestimate does not alter the conclusion suggested 
by Fig.  3  and  related  experiments in  Table II (see  below), 
namely that the fluorescent metabolites are synthesized within 
the cell, and subsequently transported to the cell surface. 
LIPSKY AND  PAGANO  tntraceliular  TransJocation  of Sphingolipids  31 Monensin Inhibits Plasma Membrane Labeling in 
a Reversible Manner 
After 30 min at 37°C  in the presence of monensin, back 
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FIGURE  3  Ability  of  back  exchange  to  remove  NBD-lipids  after 
incubation  at 37°C:  Cells were incubated  with C6-NBD-ceramide- 
containing  vesicles  at  2°C,  washed,  and  incubated  at  37°C  in 
HMEM for the indicated  time. They were then  subjected  to back 
exchange and lipids were extracted and results were calculated, as 
described  in  Materials and  Methods.  Points represent the mean ± 
SD of three to six independent experiments. (@) C6-NBD-ceramide; 
(A) NBD-sphingomyelin;  (I-l) NBD-glucocerebroside. 
TABLE  II 
Effect of Monensin on the Back Exchange  of Endogenously 
Synthesized NBD Lipids 
%  Removed by back exchange 
C6-NBD-  NBD-gluco-  NBD-sphingo- 
ceramide  cerebroside  myelin 
A.  Control  16±  11  46+  10  51  ±  10 
B.  Monensin  16 +  10  16±  12"  25 ±  12" 
C.  Reversal  8 ±  16  31  ±  7*'*  31  ±  12" 
Cells were incubated  with  C6-NBD-ceramide-containing  vesicles  at 2°C, 
washed,  and  incubated  in  HMEM  for  0.5  h  at  37°C.  They  were  then 
incubated  with  HMEM  or  subjected  to  back  exchange  as  described  in 
Materials and Methods. Fluorescent  lipids were extracted and results were 
calculated  as described.  Values are the mean  ±  SD of five to nine inde- 
pendent experiments. (A) control, (B) all steps in the presence  of 10 pM 
monensin, and (C) initial  steps were performed in the presence  of 10 pM 
monensin;  then after 10 min at 37~C, cells were washed and all subsequent 
steps were in the absence of monensin. 
* Different from control (P <  0.05). 
* Different from monensin-treated (P <  0.05). 
exchange removed significantly less of the fluorescent lipids 
(Table II). Only 16% of NBD-glucocerebroside was removed 
in  the  presence of the  inhibitor,  in  contrast to  46%  in  its 
absence, even though the total amount of NBD-glucocerebro- 
side was unchanged (see below). Similarly, only 25% of NBD- 
sphingomyelin  was  removed  in  monensin-treated  cells, 
whereas 51% was removed from controls. Again, only  16% 
of the C6-NBD-ceramide could  be removed in  either case. 
These findings are in agreement with the fluorescence micro- 
scopic observations shown in Fig.  1. This effect of monensin 
was significant after 15 rain at 37"C and persisted for at least 
45  min (data not shown). The reversibility of the monensin 
effect is also demonstrated in Table II. When monensin was 
washed out midway through the warm-up period, the amount 
of NBD-glucocerebroside that  could  be removed from the 
plasma membrane by back exchange increased significantly. 
The amount of NBD-sphingomyelin that could be removed 
also showed a  slight,  though not statistically significant, in- 
crease.  The  total  levels of metabolites during  the  reversal 
remained  the  same  as  in  the  monensin-treated  cells  (see 
below), indicating that the increase in amount of NBD-lipids 
that could be removed by back exchange was not due to new 
synthesis. 
Monensin Treatment Results in Elevated NBD- 
Sphingomyelin Levels 
The effect of monensin on overall C6-NBD-ceramide me- 
tabolism was investigated by measuring the levels of fluores- 
cent metabolites present in cells after various times at 37"C, 
in the presence and absence of monensin. Table III demon- 
strates  that  although  monensin  significantly  increased  the 
level of NBD-sphingomyelin during the warming period, C6- 
NBD-ceramide levels decreased slightly  and NBD-glucocere- 
broside levels were unaffected. 
Ability of Subcellular Fractions to Catalyze the 
Synthesis of Sphingomyelin and 
Glucocerebroside from Either C6-NBD-Ceramide 
or [3H]PalmitoyIsphingosine 
To assess the possible effect of the NBD label on ceramide 
utilization,  we  performed in  vitro  studies  to  compare C6- 
NBD-ceramide with  an  isotopically labeled  ceramide.  Cell 
homogenates were subjected to sucrose density-gradient cen- 
trifugation, and the subcellular fractions were assayed for the 
ability to convert C6-NBD-ceramide or [9,10-3H(N)]  palmi- 
toylsphingosine to the corresponding sphingomyelin and glu- 
cocerebroside.  Fig.  4a demonstrates the  similarity between 
TABLE III 
NBD Lipid Levels in the Presence and Absence of Monensin 
Total lipid fluorescence 
Min at 37°C 
0  5  15  30 
--  +  --  +  --  +  --  + 
% 
C6-NBD-ceramide  96 ±  0  93 _  2  68 -+ 5  58 _  4  44 ±  14  33 ___ 10  23 +  8  19 +  4 
NBD-glucocerebroside  --  --  19 _+ 6  20 +  6  27 _  9  28 _  8  37 +  8  31  +  7 
NBD-sphingomyelin  --  --  12 +  1  22 ±  1"  28 ±  6  39 ±  3*  40 ±  4  49 +_ 4* 
Cells were incubated with C6-NBD-ceramide-containing  vesicles at 2°C, washed, and incubated in HMEM at 37°C for the indicated  times in the absence (-) 
or presence  (+) of  10 pM  monensin.  Fluorescent  lipids  were extracted and  quantified.  The  percent of total fluorescence due  to each  metabolite was 
calculated.  Results are the mean _+ sE) of three to five independent experiments. 
* Indicates different from control (P <  0.05}. m 
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FIGURE 4  Sucrose  gradient profiles  of  enzymatic activities and 
markers of subcellular fractions: Cells were subjected to subcellular 
fractionation and fractions were assayed for the indicated activities. 
Representative gradients are shown. The ordinate represents spe- 
cific  activity relative to  that  of  the  starting  "membrane pellet," 
calculated in cpm/OD2ao or fluorescence units/OD2ao. ~2sl-WGA is 
based on precipitated cpm/#g protein. (a) [3H]Sphingomyelin  syn- 
thesis (@---@);  NBD-sphingomyelin synthesis (x  x); (b)  [3H]- 
glucocerebroside synthesis (@---@); NBD-glucocerebroside synthe- 
sis (x  x); (c)  galactosyl transferase (Golgi  marker) (@--@); 1251- 
wheat germ agglutinin (plasma membrane marker) (x---x). 
the abilities of each fraction to form the appropriate sphin- 
gomyelin from either precursor,  and  Fig.  4b demonstrates 
that the same was true for formation ofglucocerebroside. The 
peaks for all activities co-align at ~28% sucrose. This corre- 
sponds  with  the  presence  of the  Golgi  apparatus  marker 
enzyme, galactosyltransferase (Fig.  4c),  and is also in good 
agreement with other reports of the Golgi apparatus density 
(29,  30).  The same co-distribution of NBD peaks and Golgl 
fraction was obtained on three independent occasions, always 
in  the  region  of 27-29%  sucrose.  Plasma  membrane  was 
typically found in a region of~32% sucrose (Fig. 4c), whereas 
lysosomes were found at 35-40% and  10% sucrose (data not 
shown). It is unlikely that mitochondria were present at the 
density of the Golgi fraction (31), but some smooth or rough 
endoplasmic reticulum may have been present. 
DISCUSSION 
We have previously shown that C6-NBD-ceramide is metab- 
olized to fluorescent glucocerebroside and sphingomyelin in 
cultured fibroblasts at 37"C (l 5). The cells are initially labeled 
in  the  mitochondria,  endoplasmic  reticulum,  and  nuclear 
envelope, but as metabolism progresses, the Golgi apparatus 
becomes intensely labeled, and later, the plasma membrane 
becomes strongly fluorescent. The results of the present study 
are consistent with the hypothesis that both fluorescent sphin- 
gomyelin and glucocerebroside are synthesized inside the cell 
and are translocated through the Golgi apparatus before arriv- 
ing at the plasma membrane. This reasoning is based on data 
obtained from studies conducted in intact, living cells using 
the fluorescent ceramide precursor in  the presence and ab- 
sence of the ionophore monensin. 
Fluorescence microscopy revealed that if  cells that had been 
labeled  with  C6-NBD-ceramide  at  2"C  were  washed  and 
warmed to 37"C, the Golgl apparatus became intensely flu- 
orescent. After longer periods at 37"C, the plasma membrane 
became strongly labeled with both NBD-sphingomyelin and 
NBD-glucocerebroside (Table II). The fraction of each metab- 
olite  present  in  the  cell  that  could  be  removed  by  back 
exchange increased with time at 37"C,  suggesting that both 
were being delivered to the plasma membrane from an intra- 
cellular  site.  If either  compound  were  synthesized  at  the 
plasma membrane, such a time delay would not be expected. 
Because the Golgl apparatus was implicated by microscopy 
as  a  participant  in  this  metabolism,  further  studies  were 
conducted in monensin-treated ceils. It is known that monen- 
sin has multiple intracellular effects,  but is most remarkable 
for blocking the transport of secretory glycoproteins out of 
the Golgi apparatus, acting somewhere between the proximal 
and distal regions (for review, see reference 32).  Recently, it 
has been shown to block the further glycosylation of cerebro- 
sides  (33,  34).  Fluorescence  microscopy of NBD-ceramide 
labeled cells in the presence of monensin revealed the striking 
morphological changes in the Golgi apparatus characteristic 
of  this ionophore. Light and electron microscopy of fixed cells 
have established that monensin treatment leads to a swollen, 
vesiculated Golgi apparatus (32),  but to our knowledge, this 
is the first demonstration of monensin's effects in living cells. 
Monensin  treatment  markedly  reduced  visible  plasma 
membrane labeling (Fig.  I D),  and  inhibited  the  arrival  of 
both NBD-glucocerebroside and NBD-sphingomyelin at the 
cell  surface (Table  II) although  cellular levels of the  latter 
actually increased (Table III). The finding that NBD-gluco- 
cerebroside was inhibited from appearing at the plasma mem- 
brane was  not  unexpected  as  most evidence indicates that 
glycosylating enzymes are localized to microsomal or Golgi 
fractions (2,  33-36).  The inhibition  of NBD-sphingomyelin 
transport to the cell surface by monensin was more significant, 
inasmuch as the exact site of sphingomyelin biosynthesis is 
subject to dispute. 
The finding that monensin caused the cellular accumula- 
tion of NBD-sphingomyelin while retarding its appearance at 
the  plasma membrane most  strongly suggested that  NBD- 
sphingomyelin  was  synthesized  intracellularly  and  trans- 
ported through the Golgi apparatus to the plasma membrane. 
Were it to be synthesized at the plasma membrane, several 
LmSKY AND PAGANO Intracellolar  Translocation of Sphingolipids  33 findings should have resulted in this system. One might expect 
that back exchange would remove more NBD-sphingomyelin, 
and more r~pidly than it would NBD-glucocerebroside. How- 
ever, both compounds were removed in a parallel fashion. In 
the presence of monensin, which significantly raised NBD- 
sphingomyelin levels,  back exchange should have removed 
even  more  NBD-sphingomyelin;  instead,  the  amount  was 
decreased. In addition, fluorescence microscopy indicated a 
decrease in plasma membrane labeling at times where mo- 
nensin resulted in significantly increased NBD-sphingomyelin 
levels. Finally, the observation that when monensin is washed 
out,  back  exchange  reveals  the  appearance  at  the  plasma 
membrane of both fluorescent metabolites, although the total 
amounts remain unchanged, suggests that these compounds 
were accumulated inside the cell in the presence of monensin. 
To evaluate the possible effects of the fluorescent label itself 
on  ceramide  utilization,  NBD-ceramide  and  [3H]ceramide 
were given to subcellular fractions under identical conditions. 
No  preferential  metabolism  of the  radiolabeled  vs.  NBD- 
labeled  ceramide was detected  (Fig.  4),  suggesting that the 
NBD-label does not significantly alter the ability of subcellular 
fractions to  metabolize ceramide.  We  stress that  the exact 
intracellular site(s) where ceramide was converted to sphin- 
gomyelin and glucocerebroside could not be definitively es- 
tablished from our cell fractionation data alone because of 
possible  contamination of this fraction (see Results).  How- 
ever,  the  finding  of highest  activity  in  the  Golgi-enriched 
fraction corroborates the fluorescence microscopic observa- 
tions on intact cells. 
In conclusion, by using a fluorescent ceramide analogue we 
have  observed sphingolipid  metabolism  in  a  living  system 
without fixation or disruption of cells. Our results suggest that 
both the sphingomyelin and glucocerebroside analogue were 
synthesized intracetlular/y from Cr-NBD-ceramide, and were 
then  translocated through  the  Golgi  apparatus  to  the  cell 
surface. Importantly, fluorescent sphingomyelin was appar- 
ently not synthesized at the plasma membrane as has recently 
been suggested for endogenous sphingomyelin (7,  8). How- 
ever, at present we do not know how accurately the metabo- 
lism and intracellular translocation of C6-NBD-ceramide may 
reflect the behavior of endogenous ceramide.  Our findings 
that (a) exogenously supplied Cr-NBD-ceramide was metab- 
olized to the expected fluorescent products in intact ceils; (b) 
C~-NBD-ceramide  and  [3H]ceramide  were  metabolized  to 
equal extents by subcellular fractions; and (c) monensin in- 
hibits the appearance of both isotopically labeled glycosphin- 
golipids (33,  34) and fluorescent glucocerebroside at the cell 
surface suggest that the approach with fluorescent ceramide 
will be useful in further studies of sphingolipid metabolism 
and translocation in cells. 
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